Persistent Ductus Arteriosus: Clinical Trials

5 trials for Persistent Ductus Arteriosus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 31Unknown 1

Follow Persistent Ductus Arteriosus: new trials by email Literature Review of Persistent Ductus Arteriosus trials Research Report on Persistent Ductus Arteriosus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Betamethasone and Closure of Ductus Arteriosus
DA closure in a population of premature infants - Persistent Ductus Arteriosus
UnknownHospices Civils de Lyon512023-05-012024-01-18
Evaluation of the Brain and Renal Regional Oxygenation Using NIRS in Preterm Infants
NONIN SenSmart model X-100 near- infrared spectrometer - Pre-Term, Persistent Ductus Arteriosus
CompletedVilnius University1502017-11-092023-01-04
Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis
Ibuprofen in continuous (24 hours) iv infusion and EchoG, IV bolus Ibuprofen slow (15 minutes) and EchoG - Persistent Ductus Arteriosus
Phase 3UnknownInstituto de Investigación Hospital Universitario La Paz1802017-02-202020-10-29
The Best Treatment Strategy: Surgical vs Pharmacological to Close the Ductus Arteriosus Persistent in Preterm Infants
Surgical treatment, Control group - Persistent Ductus Arteriosus
Phase 2UnknownHospital General Naval de Alta Especialidad - Escuela Medico Naval402015-10-012015-11-17
The Preterm Infants' Paracetamol Study
paracetamol, 0.45 % saline solution - Persistent Ductus Arteriosus, Complication of Prematurity
Phase 2CompletedUniversity of Oulu1202013-08-012024-10-18

Narrower conditions

Ductus Arteriosus, Patent (5)  ·  Premature Birth (2)  ·  Bronchopulmonary Dysplasia (1)  ·  Pain (1)

Broader conditions

Cardiovascular Abnormalities (5)  ·  Cardiovascular Diseases (5)  ·  Congenital Abnormalities (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Heart Defects, Congenital (5)  ·  Heart Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Obstetric Labor Complications (2)  ·  Obstetric Labor, Premature (2)  ·  Pregnancy Complications (2)  ·  Urogenital Diseases (2)  ·  Infant, Newborn, Diseases (1)  ·  Infant, Premature, Diseases (1)  ·  Lung Diseases (1)  ·  Lung Injury (1)

Interventions

Acetaminophen (1)  ·  Control Groups (1)  ·  Ibuprofen (1)  ·  Infusions, Intravenous (1)  ·  Saline Solution (1)  ·  Solutions (1)  ·  Surgical Procedures, Operative (1)

Sponsors

Hospices Civils de Lyon (1)  ·  Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1)  ·  Instituto de Investigación Hospital Universitario La Paz (1)  ·  University of Oulu (1)  ·  Vilnius University (1)

Countries

Finland (1)  ·  France (1)  ·  Lithuania (1)  ·  Mexico (1)  ·  Spain (1)

Top investigators

Augustina Jankauskiene, MD (1)  ·  Mikko Hallman, M.D., Ph.D. (1)  ·  Timo Saarela, M.D., Ph. D. (1)

Results publications

PMID 15701582, PMID 16219273, PMID 17307530, PMID 18254095, PMID 19128748, PMID 23234752, PMID 23543702, PMID 24753708, PMID 24815768, PMID 25046256, PMID 25346899, PMID 25835756, PMID 27215779, PMID 34886825, PMID 36519620, PMID 39604779

NIH funding

2016 (1)